ストックスクリーナーアプリを入手
12.35
4.31%
0.51
前日終値:
$11.84
開ける：
$11.98
24時間の取引高:
849.03K
Relative Volume:
0.67
時価総額：
$889.87M
収益：
-
当期純損益:
$-4.81M
株価収益率:
-24.71
EPS:
-0.4998
ネットキャッシュフロー:
$-122.54M
1週間 パフォーマンス:
+7.30%
1か月 パフォーマンス:
+10.37%
6か月 パフォーマンス:
+18.52%
1年 パフォーマンス:
+79.77%
1日の値動き範囲:
$11.92
$12.57
1週間の範囲:
$11.25
$12.57
52週間の値動き範囲:
$2.95
$17.65
Omeros Corporation Stock (OMER) Company Profile
名前
Omeros Corporation
セクター
電話
206-676-5000
住所
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
12.36 | 852.43M | 0 | -4.81M | -122.54M | -0.4998 |
VRTX
Vertex Pharmaceuticals Inc
|
443.87 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
750.30 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
842.78 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
336.14 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.56 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-10 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-23 | 開始されました | D. Boral Capital | Buy |
| 2024-11-14 | 開始されました | Rodman & Renshaw | Buy |
| 2022-12-08 | ダウングレード | UBS | Buy → Neutral |
| 2022-11-08 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-06-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-10-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2021-10-01 | ダウングレード | Wedbush | Neutral → Underperform |
| 2021-09-27 | 開始されました | JP Morgan | Neutral |
| 2021-02-01 | 開始されました | UBS | Buy |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-08-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-14 | 繰り返されました | Maxim Group | Buy |
| 2019-05-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-07-12 | 開始されました | Seaport Global Securities | Buy |
| 2018-03-23 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-03-05 | ダウングレード | Needham | Buy → Hold |
| 2017-11-08 | 開始されました | H.C. Wainwright | Buy |
| 2017-05-11 | ダウングレード | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | 繰り返されました | Maxim Group | Buy |
| 2017-03-17 | 繰り返されました | Needham | Buy |
| 2016-11-16 | 繰り返されました | Wedbush | Outperform |
| 2016-11-10 | 繰り返されました | Needham | Buy |
| 2016-08-10 | 繰り返されました | Maxim Group | Buy |
| 2016-06-03 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-02 | 繰り返されました | Needham | Buy |
| 2016-02-29 | 繰り返されました | Wedbush | Outperform |
| 2015-11-11 | 繰り返されました | Needham | Buy |
| 2015-08-18 | 繰り返されました | WBB Securities | Strong Buy |
| 2015-08-10 | 開始されました | ROTH Capital | Buy |
すべてを表示
Omeros Corporation (OMER) 最新ニュース
Published on: 2026-04-14 03:02:37 - baoquankhu1.vn
OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN
Omeros rises as Novo deal boosts Q4 earnings - MSN
Omeros Corporation (NASDAQ:OMER) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect? - Yahoo Finance
OMER News | OMEROS CORP (NASDAQ:OMER) - ChartMill
Earnings Risk: What is the long term forecast for Omeros Corporation stock2026 Technicals & Weekly Momentum Picks - baoquankhu1.vn
Omeros expects YARTEMLEA to be financially self-sustaining in 2026 and targets positive cash flow in 2027 - MSN
Omeros Corporation $OMER Shares Sold by Newbridge Financial Services Group Inc. - MarketBeat
JPMorgan Chase & Co. Boosts Holdings in Omeros Corporation $OMER - MarketBeat
Risk Recap: Is Omeros Corporation impacted by rising ratesGap Up & Daily Entry Point Trade Alerts - baoquankhu1.vn
Omeros Achieves Profitability as Strategic Moves Slash Debt - AD HOC NEWS
Breakout Zone: Is Omeros Corporation impacted by rising rates2026 Summary & Safe Entry Point Identification - baoquankhu1.vn
Omeros (NASDAQ:OMER) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch - TipRanks
Omeros Q4 2025 earnings preview - MSN
HC Wainwright Brokers Increase Earnings Estimates for Omeros - MarketBeat
Travel Stocks: Can Omeros Corporation withstand a market correctionMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Omeros (NASDAQ:OMER) Shares Down 6.5%Here's Why - MarketBeat
Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates (OMER) - Seeking Alpha
Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript - Insider Monkey
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros Shares Surge on Stellar Earnings and Strategic Progress - AD HOC NEWS
Omeros stock rises after Q4 earnings beat (OMER:NASDAQ) - Seeking Alpha
Omeros Sees Unusually Large Options Volume (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - MarketBeat
Omeros Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Omeros reports Q4 EPS $1.22, consensus 36c - TipRanks
Transcript : Omeros Corporation, Q4 2025 Earnings Call, Mar 31, 2026 - marketscreener.com
Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaroun - GuruFocus
Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $3.69 EPS - MarketBeat
Omeros Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Omeros Corporation Reports Q4 and Full-Year 2025 Results - National Today
Omeros Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat By Investing.com - Investing.com South Africa
Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat - Investing.com
Omeros (OMER) Posts Strong Q4 Results Amid Strategic Advances - GuruFocus
OMEROS ($OMER) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Omeros: Q4 Earnings Snapshot - marketscreener.com
Omeros (NASDAQ: OMER) wins TA‑TMA approval and $240M Novo Nordisk pact - Stock Titan
Omeros Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results - The Joplin Globe
BRIEF-Omeros Corporation Q4 EPS USD 1.22 - TradingView — Track All Markets
After $240M Novo deal, Omeros launches first approved TA-TMA drug - Stock Titan
Omeros Corporation (OMER) 財務データ
収益
当期純利益
現金流量
EPS
Omeros Corporation (OMER) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Borges David J. | VP, Finance & CAO |
Jan 13 '26 |
Option Exercise |
3.06 |
30,000 |
91,800 |
30,000 |
| Borges David J. | VP, Finance & CAO |
Jan 12 '26 |
Sale |
12.72 |
30,000 |
381,600 |
0 |
| Borges David J. | VP, Finance & CAO |
Jan 13 '26 |
Sale |
12.31 |
30,000 |
369,315 |
0 |
2.64%
0.19%
大文字化:
|
ボリューム (24 時間):